DCF — TROUSDALE MEDICAL CENTER
Enterprise Value: $9.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$9.1M
Enterprise Value
$2.4M
PV of Cash Flows
$6.7M
PV of Terminal Value
$10.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $12.0M | $1.2M | 10.0% | $0.5M | $0.4M |
| Year 2 | $12.4M | $1.3M | 11.0% | $0.6M | $0.5M |
| Year 3 | $12.8M | $1.5M | 12.0% | $0.7M | $0.5M |
| Year 4 | $13.2M | $1.6M | 12.0% | $0.7M | $0.5M |
| Year 5 | $13.6M | $1.7M | 13.0% | $0.8M | $0.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $9.1M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$11.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.09365126062605153
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5